Skip to content

Clinical trials

Phase 4 Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 4 Country / region: United States Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20034
20045
20066
20071
20083
20094
20102
20113
20121
20135
20141
20152
20161
20172
20184
20193
20202
20211
20221
20231
20243
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated10
Unknown status7
Withdrawn4
Recruiting4
Active, not recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Brigham and Women's Hospital2
Cancer Center of Irvine2
GlaxoSmithKline2
Hoffmann-La Roche2
Inovio Pharmaceuticals2
M.D. Anderson Cancer Center2
Mayo Clinic2
Pfizer2
University of Florida2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms59
Prostatic Neoplasms6
Neuroendocrine Tumors3
Pain3
Breast Neoplasms2
Carcinoma2
Glioma2
Leukemia2
Lung Neoplasms2
Neoplasms by Site2

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.